MarkFrakesMD

PubMed

• 16 citations
  Mechanism of Action of G-Quadruplex–Forming Oligonucleotide Homologous to the Telomere Overhang in Melanoma
  Gagan Chhabra, Luke Wojdyla, Mark Frakes, Zachary Schrank, Brandon Leviskas, Marko Ivancich, Pooja Vinay, Ramesh Ganapathy, Benjamin E. Ramirez, Neelu Puri> ;The Journal of Investigative Dermatology. 2017 Dec 2
• 9 citations
  Current Molecularly Targeting Therapies in NSCLC and Melanoma
  Supriya Rajanna, Ichwaku Rastogi, Luke Wojdyla, Hiroko Furo, Agnes Kulesza, Lin Leo S, Bonnie Sheu, Mark Frakes, Marko Ivanovich, Neelu Puri> ;Anti-Cancer Agents in Medicinal Chemistry. 2015 Aug 31

Journal Articles

• EGFR and c-Met Inhibitors are Effective in Reducing Tumorigenicity in Cancer.  
  Stone A, Harrington K, Frakes M, Blank K, Rajanna S, Rastogi I, Puri N., Journal of Cancinogenesis, 2014
• c-Met: A Potential Target for Current Non-Small-Cell Lung Cancer Therapeutics.  
  Stone A, Rajanna S, Rastogi I, Cruz J, Harrington K, Blank K, Frakes M, Puri N., Chemotherapy, 2014

Books/Book Chapters

• Cancer Therapeutic Targets 
  Chapter: Telomerase-related Proteins 
  Page 1 - 11Wojdyla L, Frakes M, Harrington K, Stone A, Puri N.2016

Abstracts/Posters

• Adenoma prevalence among varying demographics undergoing colonoscopy at a family medicine residency.
  Frakes M, Akinlotan M, McKnight J, Bolin J, Nguyen V, Pope R, McClellan D, Pekarek K. Adenoma, American Association for Primary Care Endoscopy CME 2018 CME Conference and Membership Meeting, 11/2/2018
• Investigating mechanism of action of oligonucleotides homologous to the telomere overhang in melanoma
  Frakes M, Wojdyla L, Ivancich M, Fortinberry P, Vinay P, Pandey P, Chhabra G, Puri N., American Association for Cancer Research, 2016